138 related articles for article (PubMed ID: 35656850)
41. Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years.
Li W; Branley J; Sud A
Infection; 2018 Jun; 46(3):349-355. PubMed ID: 29464675
[TBL] [Abstract][Full Text] [Related]
42. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
Mackintosh CL; White HA; Seaton RA
J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914
[TBL] [Abstract][Full Text] [Related]
43. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
44. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].
Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L
Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802
[TBL] [Abstract][Full Text] [Related]
45. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention.
Moran E; Masters S; Berendt AR; McLardy-Smith P; Byren I; Atkins BL
J Infect; 2007 Jul; 55(1):1-7. PubMed ID: 17343916
[TBL] [Abstract][Full Text] [Related]
46. Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection.
Kaasch AJ; Rommerskirchen A; Hellmich M; Fätkenheuer G; Prinz-Langenohl R; Rieg S; Kern WV; Seifert H;
Trials; 2020 Feb; 21(1):175. PubMed ID: 32051007
[TBL] [Abstract][Full Text] [Related]
47. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Heldman AW; Hartert TV; Ray SC; Daoud EG; Kowalski TE; Pompili VJ; Sisson SD; Tidmore WC; vom Eigen KA; Goodman SN; Lietman PS; Petty BG; Flexner C
Am J Med; 1996 Jul; 101(1):68-76. PubMed ID: 8686718
[TBL] [Abstract][Full Text] [Related]
48. Intravenous to oral switch therapy in cancer patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus: A single-center retrospective observational study.
Itoh N; Hadano Y; Saito S; Myokai M; Nakamura Y; Kurai H
PLoS One; 2018; 13(11):e0207413. PubMed ID: 30496212
[TBL] [Abstract][Full Text] [Related]
49. A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).
Muldoon EG; Switkowski K; Tice A; Snydman DR; Allison GM
Infect Dis (Lond); 2015 Jan; 47(1):39-45. PubMed ID: 25415655
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
[TBL] [Abstract][Full Text] [Related]
51. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
[TBL] [Abstract][Full Text] [Related]
52. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
[TBL] [Abstract][Full Text] [Related]
53. Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy.
Sharma R; Loomis W; Brown RB
Am J Med Sci; 2005 Aug; 330(2):60-4. PubMed ID: 16103785
[TBL] [Abstract][Full Text] [Related]
54. Feasibility and Safety of Outpatient Parenteral Antimicrobial Therapy in Conjunction With Addiction Treatment for People Who Inject Drugs.
Price CN; Solomon DA; Johnson JA; Montgomery MW; Martin B; Suzuki J
J Infect Dis; 2020 Sep; 222(Suppl 5):S494-S498. PubMed ID: 32877541
[TBL] [Abstract][Full Text] [Related]
55. Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship.
Siqueira MB; Saleh A; Klika AK; O'Rourke C; Schmitt S; Higuera CA; Barsoum WK
J Bone Joint Surg Am; 2015 Aug; 97(15):1220-32. PubMed ID: 26246256
[TBL] [Abstract][Full Text] [Related]
56. Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial.
Turner NA; Zaharoff S; King H; Evans S; Hamasaki T; Lodise T; Ghazaryan V; Beresnev T; Riccobene T; Patel R; Doernberg SB; Rappo U; Fowler VG; Holland TL;
Trials; 2022 May; 23(1):407. PubMed ID: 35578360
[TBL] [Abstract][Full Text] [Related]
57. Suppressive antibiotic therapy with oral doxycycline for Staphylococcus aureus prosthetic joint infection: a retrospective study of 39 patients.
Pradier M; Nguyen S; Robineau O; Titecat M; Blondiaux N; Valette M; Loïez C; Beltrand E; Dézeque H; Migaud H; Senneville E
Int J Antimicrob Agents; 2017 Sep; 50(3):447-452. PubMed ID: 28668689
[TBL] [Abstract][Full Text] [Related]
58. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.
Suleyman G; Kenney R; Zervos MJ; Weinmann A
J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899
[TBL] [Abstract][Full Text] [Related]
59. Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange.
Ascione T; Pagliano P; Balato G; Mariconda M; Rotondo R; Esposito S
J Arthroplasty; 2017 Jul; 32(7):2239-2243. PubMed ID: 28372916
[TBL] [Abstract][Full Text] [Related]
60. The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs.
Douglass AH; Mayer H; Young K; Sikka MK; Strnad L; Makadia J; Sukerman E; Lewis JS; Streifel AC
Ther Adv Infect Dis; 2023; 10():20499361231189405. PubMed ID: 37581105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
